Target intelligence / Profile preview

Luminal water (LWF)

Target
LWF
Molecular classification
Other
01

Overview

Luminal water refers to the aqueous fluid contained within the internal cavities or lumens of tubular organs, most significantly the gastrointestinal tract and the prostate gland (Schiller et al., 2010). In the intestines, the volume of luminal water is a primary determinant of stool consistency and motility, and it is tightly regulated by the transport of electrolytes across the epithelial barrier (Ford et al., 2014). While luminal water is a physiological substance rather than a specific molecular receptor or enzyme, it serves as the functional endpoint for various pharmacological agents, such as osmotic laxatives (e.g., polyethylene glycol) and secretagogues (e.g., linaclotide), which aim to increase water content to alleviate constipation (Lembo et al., 2011). In the field of diagnostic imaging, the Luminal Water Fraction (LWF) is a specialized MRI-based biomarker used to detect and characterize prostate cancer (Sabouri et al., 2017). Malignant transformation in the prostate typically involves the loss of fluid-filled ductal spaces, resulting in a measurable decrease in LWF, which correlates with tumor aggressiveness (Dregely et al., 2016). Consequently, luminal water is a critical parameter in both the management of functional bowel disorders and the non-invasive assessment of prostatic health.

Other names
Intestinal luminal waterLuminal water contentLuminal water fractionLWF
02

Mechanism of action

Modulation of luminal water is achieved through osmotic retention of fluid or by stimulating the active secretion of ions (e.g., chloride and bicarbonate) into the lumen via channels like CFTR or GC-C, which draws water in through osmosis (Schiller et al., 2010; Currie et al., 2014).

03

Biological functions

Osmotic regulationFluid homeostasisLubrication of the alimentary canalWaste transport and excretion
04

Disease associations

Chronic idiopathic constipationIrritable bowel syndrome with constipation (IBS-C)Prostate cancerDiarrhea
05

Safety considerations

DehydrationElectrolyte imbalance (e.g., hypokalemia, hyponatremia)Abdominal crampingSevere diarrhea
06

Interacting drugs

Polyethylene glycol

6 more in the full profile.

07

Biomarkers

Luminal Water Fraction (LWF) in MRIBristol Stool ScaleFecal water contentT2 relaxation time

Beyond the preview

Go deeper on Luminal water (LWF).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Luminal water (LWF).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call